Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Community
/
Ideas
/
GLENMARK - Q1 RESULTS AND OBSERVATIONS
GLENMARK PHARMACEUTICALS
Long
GLENMARK - Q1 RESULTS AND OBSERVATIONS
By Sunandamedi
Follow
Follow
Aug 14, 2020
0
Aug 14, 2020
Q1 2020, results
Financials Q1 FY2020-21 Q1 FY2019-20 % Change
Total Income ₹ 2403.30 crs ₹ 2324.54 crs Up Tick 3.39%
Net Profit ₹ 254.04 crs ₹ 109.28 crs Up Tick 132.47%
EPS ₹ 9 ₹ 3.87 Up Tick 132.56%.
THE FACTOR FOR 3% INCREASE IN TOP LINE IS NOT SO GOOD. BUT, THE PANDEMIC SITUATION SALES ARE GOOD. Q2 SHOULD BE FURTHER IMPROVED.
Beyond Technical Analysis
Chart Patterns
Technical Indicators
Sunandamedi
Follow
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.